Highlighting the critical role of EZH2 and HCMV in our glioblastoma model, the impact of EZH2 inhibitor (GSK343) and anti-HCMV drug ganciclovir (GCV) alone and in combination with TMZ was assessed. The gene discussed is EZH2; the disease is glioblastoma.